49 results about "Bursitis" patented technology

This invention relates to methods for medical treatment of a variety of pathological conditions associated with bone environments and musculoskeletal environments, including the treatment of ischemic conditions such as bursitis. The method involves applying a sufficient number of acoustic shock waves to the site of a pathological condition including micro-disruptions, non-osseous tissue stimulation, increased vascularization, and circulation and induction of growth factors to induce or accelerate the body's natural healing processes and responses.

The present invention provides compositions, combination of medicaments, and methods for the treatment of certain conditions such as arthritis, and in particular, reactive arthritis, osteoarthritis, and bursitis, among others.

A method including topically administering an effective amount of local anesthetic to a patient is disclosed. The method is effective for inducing analgesia for treating non-neuropathic pain. Non-neuropathic pain suitable for treatment according to the invention includes pain associated with sports injuries; sprains; strains; soft-tissue injury; repetitive motion injury; carpal tunnel syndrome; injury to tendons, ligament, and muscles; conditions such as fibromyalgia, bursitis, castrochondritis, myofascial pain, and pain associated with arthritis, inflammation, contusions, post-surgical pain, and nociceptive pain. Preferably, the lidocaine is applied via a transdermal patch applied near the locus of pain.

The present invention provides compositions, combination of medicaments, and methods for the treatment of certain conditions such as arthritis, and in particular, reactive arthritis, osteoarthritis, and bursitis, among others.

The present disclosure is directed to modulators of cyclooxygenase (COX) enzymes and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment and / or management of the severity and duration of non-specific pain, tension-type pain, headache, migraine, lower back pain, sciatica, dental pain, muscular pain, pain associated with acute soft tissue injuries, bursitis, tendonitis, lumbago, periarthritis, tennis elbow, sprains, strains, muscular problems associated with sports injuries, muscular problems associated with accidents, period pain, primary dysmenorrhoea, acute sore throat pain, osteoarthritis, rheumatoid arthritis, cancer, any disorder requiring analgesic response, any disorder requiring anti-inflammatory response, any disorder requiring antipyretic response, any conditions mediated by cyclooxygenase, cystic fibrosis, dementia, Alzheimer's disease, and / or conditions mediated by levels of β-amyloid are described.

A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of a member from each of the following groups of medications: (1) synthetic purine nucleoside analog antiviral drugs, (2) antibiotic drugs, and (3) imidazole drugs. Alternate embodiments of the invention include dual combinations of (A) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the antibiotic group of drugs, (B) a member of the antibiotic group of drugs and a member of the imidazole family of drugs, and (C) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the imidazole group of drugs.

Hip brace for motion control and support of the hip joint, and / or to the surrounding sacroiliac joint and / or lumbo-sacral joints concomitantly, built of configured elasticized neoprene with tensile strength, and with closures built of Velcro whose combined forces impart dynamic action and protection from hip dislocation and subluxation; range of motion control, joint protection and support, pain management, proprioceptive cueing, alignment support, resistive and assistive exercise options for people with disorders of the hip joint and as well for those with concomitant sacroiliac and lumbo-sacral instability. Medical conditions addressed include but not limited to hip pain, status post surgical hip, hip dislocation / subluxation, arthritis, sprains, strains, bursitis, tendonitis, joint hypermobility, ligamentous tears and sacroiliac and / or lumbo-sacral pain and instability, radiculitis as well as for athletes in need of hip joint and / or the sacroiliac, lumbo-sacral joint protection and support on and off the field and for everyday activities of daily living (ADL) and exercise.

A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the tetracycline family, and a member of the nitroimidazole family, or alternatively, administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the beta-lactam family, and a member of the nitroimidazole family, or alternatively, administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the macrolide antimicrobial family, and a member of the nitroimidazole family, or alternatively, administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the ketolide antimicrobial family, and a member of the nitroimidazole family.

A treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising a combination of valacyclovir hydrochloride, minocycline hydrochloride, and metronidazole.

WEARABLE, PRE-CALIBRATED & HANDS-FREE CLINICAL-STRENGTH medical device / s for JOINT PAIN RELIEF using a sports / orthopedic brace / wrap (for Wrist, Knee, Elbow, Neck & Shoulder, Ankle & Foot & Back) embedded with therapeutic Low Level Laser therapy (LLLT) based red light (infrared and near infrared) technology. —A convenient PORTABLE device for pain relief from joint related musculoskeletal pain caused by illnesses including—TENDONITIS (BACK PAIN, KNEE TENDONITIS, HAND TENDONITIS, ACHILLES TENDONITIS) TENNIS ELBOW, CARPEL-TUNNEL, ARTHRITIS, OSTEOPEROSIS, PLANTAR FASCITIS, TISSUE HEALING from SPORTS INJURIES AND BURSITIS, and as an non-invasive alternative to NSAIDs (Non-Steroidal Anti Inflammatory Drugs)

The present invention relates to a method for treating a subject for a condition or inflammation associated with oedema, excess body fluids or oedema and excess body fluids, or for treating a subject for an abscess, boil, blister or cyst. The method comprises applying to the skin surface covering a body part or region affected by said condition, inflammation, abscess, boil, blister or cyst a composition capable of transdermally attracting fluids from the body part or region or its proximity, wherein said composition comprises at least one adsorptive or absorptive agent, and leaving said composition in contact with the skin for sufficient time to allow said composition to transdermally absorb or adsorb at least a portion of the body fluids from said body part or region. The present invention also relates to compositions for absorbing or adsorbing fluids from a body part or region, and which are capable of transdermally attracting fluids from body parts or regions or their proximity.

A bursitis treatment device (100; 200) for treatment of inflammation of a bursa (150; 502) in a patient's joint includes:a rinsing aid;a reservoir (101; 201) for holding the rinsing aid in fluid, freezing fluid or gaseous state;a supply line (103; 204, 208) for transporting the rinsing aid;a heat exchanger (104; 203) for controlling the temperature of the rinsing aid—such that the temperature of the rinsing aid enables to destroy cells causing the inflammation;an access device (209) for injecting the rinsing aid into the bursa (150; 205); anda drain (105; 210) for removing the rinsing aid from the bursa (150; 205) for elimination.

A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the tetracycline family, and a member of the nitroimidazole family, or alternatively, administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the quinolone family, and a member of the nitroimidazole family.

A Chinese medicine in the form of ointment for treating rheumatoid arthritis, lumbar intervertebral disc protrusion and bursitis is prepared from 10 Chinese-medicinal materials including black pepper, toad venom, beeswax, Dragon's blood, etc. Its preparing process is also disclosed.

A Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness which alleviates pain and inflammation from muscle strain, spasms, arthritis, and bursitis. The composition and method for alleviation of pain and inflammation generally includes a combination of Lidocaine HCL, camphor, menthol, Bisabolol, glucosamine hydrochloride (glucosamine HCI), chondroitin, and MSM, along with a number of other ingredients. The composition described and claimed herein has been shown to alleviate pain and inflammation from injuries and conditions such as muscle strains, spasms, arthritis, and bursitis. The composition will preferably be incorporated into a topical cream which may be applied to the skin around the affected area to provide not only immediate relief from pain and inflammation, but also long-lasting relief which may last for days or even weeks.

This invention provides compositions and methods for preventing inflammatory diseases of the joints, including rheumatoid and osteoarthritis, tendonitis, bursitis, inflammation of the ligament, synovitis, gout, and systemic lupus erythematosus, wherein the methods include injecting into the inflamed joint a therapeutic anti-inflammatory composition comprising a bacterial or viral IL-10 expression construct, wherein the IL-10 expression construct comprises a bacterial or viral backbone and a nucleic acid sequence encoding interleukin-10.

The veterinary medicine consists of tetrandra root, Radix Bupleuri, herb of red tassel flower, Herba Andrographitis and paste prepared with selfheal and taraxacum. It is used to treat indigestion, dysentery, Fabricius bursitis, asthma, anorexy, die back disease, etc. of farm animal, and has high curative effect, no resistance and no toxic side effect.

The invention relates to a Chinese herbal medicine, in particular to a medicament for treating traumatic joint periostitis and bursitis, which is characterized by comprising the following medicinal materials in weight ratio: 15-30g of honeysuckle, 10-15g of weeping forsythia, 15-30g of taraxacum, 15-30g of small red beans, 10-15g of radix stephaniae tetrandrae, 10-15g of pubescent angelica, 10-15g of angelica sinensis, 15-30g of caulis spatholobi, 15-25g of red peony root, 10-15g of achyranthis bidentatae, 10-15g of plantain seed and 15-30g of coixseed. The medicament can be taken by the following rules: a dose per day; twice a day after breakfast and supper, 100 ml each time, wherein each dose of the medicament is decocted twice by the steps of; decocting 20 minutes by slow fire after boiling for the first time; and decocting for 25 minutes by slow fire after boiling for the second time; taking 100ml of decoction after each decocting and mixing. The invention has the advantages of clearing heat, reducing swelling, cooling blood, dredging channels, diminishing inflammation, relieving pains, little toxicity, no side effect, high safety and the like.

The present disclosure is directed to modulators of cyclooxygenase (COX) enzymes and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment and / or management of the severity and duration of non-specific pain, tension-type pain, headache, migraine, lower back pain, sciatica, dental pain, muscular pain, pain associated with acute soft tissue injuries, bursitis, tendonitis, lumbago, periarthritis, tennis elbow, sprains, strains, muscular problems associated with sports injuries, muscular problems associated with accidents, period pain, primary dysmenorrhoea, acute sore throat pain, osteoarthritis, rheumatoid arthritis, cancer, any disorder requiring analgesic response, any disorder requiring anti- inflammatory response, any disorder requiring antipyretic response, any conditions mediated by cyclooxygenase, cystic fibrosis, dementia, Alzheimer's disease, and / or conditions mediated by levels of beta-amyloid are described.

The present disclosure is drawn to methods for treating nerve entrapment pain; neuroma pain; headache associated with neuralgia; connective tissue pain such as iliotibial band pain, blood vessel pain, tendinopathy pain, medial tibial stress syndrome pain, bursitis, etc.; arthritis pain such as osteoarthritis pain or rheumatoid arthritis pain; pain associated with injury such as fracture, severance, break, sprain, strain, tear, point pain, (e.g., trigger point pain or hit point pain), focal pain, or bruise; or combinations of these pains. Specifically, a method for treating various types of pain includes the application of an analgesic system to a skin surface of a subject experiencing the pain and maintaining the analgesic system on the skin surface for a period of time of at least 30 minutes. The analgesic system applied to the skin surface can include a heating component and a local anesthetic formulation which includes at least one local anesthetic. The heating component can be capable of heating the skin surface to a temperature of 36° C. to 42° C.

The invention discloses an externally-applied plaster for treating synovitis, which is prepared from the following raw materials according to parts by weight: 15-17 parts of wolfberry root-bark, 15-17 parts of pyrolusite, 19-21 parts of mastic, 19-21 parts of myrrh, 15-17 parts of unprocessed radix aconiti lateralis, 15-17 parts of shengnanxing, 15-17 parts of tuber pinellia, 15-17 parts of radix sileris, 15-17 parts of radix aconiti, 15-17 parts of kusnezoff monkshood, 65-70 parts of minium, 6-9 parts of borneol and 130-150 parts of sesame oil. The invention has strong permeability, has the effects of dispersing pathogenic wind, relieving pain, strengthening the bone and the tendon, eliminating the pathogenic factor and removing dampness and has a specific action mainly aiming at gonarthromeningitis, bursitis and the synovitis of each joint part.

The invention relates to an externally applied traditional Chinese medicine used for treating hyperosteogeny, acute lumbar sprain and articular bursitis. The medicine is characterized by being made of the following raw materials: 8% of angelica, 8% of safflower, 5% of eupolyphaga, 5% of ledebouriella root, 5% of Chinese flowering quince, 8% of notoperygium root, 8% of pubescent angelica root, 8% of Chinese clematis, 8% of parasitic loranthus, 8% of notoginseng, 5% of atractylodes rhizome, 8% of Chinese teasel root, 8% of mulberry twig and 8% of camphor, and all the raw materials are ground into powder, then the powder is evenly mixed and put into a paper envelope, and the weight of each paper envelope is 30-50g. The medicine is for external use. The paper envelope is lay flat on an affected portion, 60-degree Chinese liquor is dropped into one side of the paper envelope, and the paper envelope is lay on the affected portion for 2 hours once and for once a day, and 7 days is a treatment course. The medicine has the efficacies of tonifying the kidney to consolidate the body resistance, dispelling pathogenic wind and removing dampness, subduing swelling and relieving pain, and relaxing muscles and tendons and activating the channels. The medicine has the advantages of short curing time, convenient administration, quick effects on activating the blood circulation and subduing the swelling and relieving pain. General symptoms can be cured after one treatment course, and the severe symptoms can be cured in three treatment course.

The invention relates to a method for treating a subject for a bursitis. The method comprises applying to the skin surface covering a body part or region affected by the bursitis a composition capable of transdermally attracting fluids from the body part or region or its proximity, wherein the composition includes at least one adsorptive or absorptive agent, and leaving the composition in contact with the skin for sufficient time to allow the composition to transdermally absorb or adsorb at least a portion of the body fluids from the body part or region.

The invention discloses an externally-applied plaster for treating synovitis, which is prepared from the following raw materials according to parts by weight: 15-17 parts of wolfberry root-bark, 15-17 parts of pyrolusite, 19-21 parts of mastic, 19-21 parts of myrrh, 15-17 parts of unprocessed radix aconiti lateralis, 15-17 parts of shengnanxing, 15-17 parts of tuber pinellia, 15-17 parts of radixsileris, 15-17 parts of radix aconiti, 15-17 parts of kusnezoff monkshood, 65-70 parts of minium, 6-9 parts of borneol and 130-150 parts of sesame oil. The invention has strong permeability, has the effects of dispersing pathogenic wind, relieving pain, strengthening the bone and the tendon, eliminating the pathogenic factor and removing dampness and has a specific action mainly aiming at gonarthromeningitis, bursitis and the synovitis of each joint part.

The invention provides a formula for a bone fracture cream and a preparation method of the bone fracture cream, and relates to the field of traditional Chinese medicine. The bone fracture cream is prepared from the following raw materials: myrrh, kudzuvine root, peach kernels, ground beeltle, Chinese herbaceous peony, centipede, niu teng, mulberry twig, garden balsam stem, common clubmoss herb, pawpaw, notopterygium root, achyranthes, pinellia ternate, radix aconiti, hippocampus, frankincense, cinnamomum cassia, safflower carthamus, radix clematidis, cassia twig, pangolin, corydalis tuber, salvia miltiorrhiza water snake, Chinese alangium, rhizome zingiberis, garter snake, radix angelicae pubescentis, leaf artemisia, arisaema heterophyllum blume, pseudo-ginseng and radix saphshnikoviae. After the technical scheme of the formula for the bone fracture cream is adopted, the formula for the bone fracture cream has the beneficial effects that the bone fracture cream can treat diseases of toothache, cervical spondylosis, scapulohumeral periarthritis, hyperplasia of mammary glands, lumbar pain, lumbar spinal stenosis, lumbar muscle degeneration, enteritis, ischiadic nerve, dysmenorrhea, knee pain, rheumatism, arthritis, arthrocele, arthromeningitis, bursitis, achilles tendinitis, heel pain, traumatic injury, hyperplasia, sprain and postpartum style, wind driving and cold dissipating are achieved, tendons and collaterals activating are achieved, the treating effect is improved, and the treating range is enlarged.

The invention provides a traditional Chinese medicine wine for treating bursitis. The traditional Chinese medicine wine is prepared by taking codonopsis convolvulacea, longtube ground ivy herb, aralia chinensis root, garden balsam stem, cablin potchouli herb, radix rehmanniae preparata, roughhair fig root, Chinese taxillus twigs, root of mountain spicy tree, bright salt, fruits of purpleflower holly, argy wormwood leaves, malaytea scurfpea fruits, leaves and twigs of fruticose breynia, clematis root, littleleaf photinia root, conic gymnadenia rhizome, desertliving cistanche, phoenix dates, inebriate achnatherum herb and root, silkworm excrement, peach seeds and liquor as raw materials. The traditional Chinese medicine wine provided by the invention has the beneficial effects that the traditional Chinese medicine wine provided by the invention has strong penetrability, is mainly used for treating non-infectious bursitis, can directly act on an affected part, can be used by combining internal use and external use and can promote blood circulation, remove blood stasis, remove swelling, relieve pain, dispel wind, dispel cold, realize aromatic resuscitation, supplement qi, benefit blood, nourish liver and kidney, promote blood circulation at the affected part, improve the nutritional status of a synovial membrane, protect the synovial membrane and rapidly and effectively reduce the suffering of a patient.

This invention provides compositions and methods for preventing inflammatory diseases of the joints, including rheumatoid and osteoarthritis, tendonitis, bursitis, inflammation of the ligament, synovitis, gout, and systemic lupus erythematosus, wherein the methods include injecting into the inflamed joint a therapeutic anti-inflammatory composition comprising a bacterial or viral IL-10 expression construct, wherein the IL-10 expression construct comprises a bacterial or viral backbone and a nucleic acid sequence encoding interleukin-10.

The present invention provides a unique, compact, soft-cushioned, multi-directional, 360° gliding arm rest pad device which effectively eliminates forearm-to-pad friction during movement of a user's arm in any direction when operating a device, such as a computer mouse, a joystick or any other equipment that may place stress and strain on one's hands, arms, and elbows. The multi-directional gliding arm rest pad device allows free movement of a user's forearm to glide multi-directionally with minimal tension resistance, so that shoulder strain is substantially reduced, development of bursitis, carpal tunnel syndrome, cubital tunnel syndrome, and elbow pain is greatly diminished, and a user's functional work performance duration time is extended due to reduction of hand and arm fatigue afforded by the smooth and effortless directional movement of the arm rest pad.

A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of a member from each of the following groups of medications: (1) synthetic purine nucleoside analog antiviral drugs, (2) antibiotic drugs, and (3) imidazole drugs. Alternate embodiments of the invention include dual combinations of (A) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the antibiotic group of drugs, (B) a member of the antibiotic group of drugs and a member of the imidazole family of drugs, and (C) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the imidazole group of drugs.

The invention discloses a medicinal composition for treating arthromeningitis. The medicinal composition comprises the following raw materials in parts by weight: 10-20 parts of Sichuan rhizoma coptidis, 12-20 parts of rhizoma smilacis glabrae, 15-25 parts of prepared radix aconiti carmichaeli, 15-25 parts of dwarf lilyturf tuber, 10-15 parts of scorpio and 10-20 parts of red peony root. The medicinal composition for treating the arthromeningitis, provided by the invention, has the beneficial effects of promoting Qi circulation, stopping pain, dispelling wind, removing dampness, strengthening bones and muscles, eliminating evil, removing dampness and activating and dredging meridians, and has a special effect on arthromeningitis and bursitis of a knee joint and arthromeningitis of other joints.